Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation

RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and compared the safety profiles of newer contraceptives using 43,324 adverse event case reports submitted to the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), for the two years ending July 2017.  The presentation on Saturday, March 10, 2018 in San Diego described the strong safety profiles of the newer contraceptives, as well as issues of concern.

For more details see the presentation poster here.

 

Posted in

More RSI News

QuarterWatch analyzes MedWatch Reports

June 29, 2016
RSI logo in white

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…

Read News Item

Climate change modelling for the Bow River watershed

June 29, 2016
RSI logo in white

Developing a suite of watershed-scale climate models.

Read News Item

QuarterWatch analyzes MedWatch Reports

June 29, 2016
RSI logo in white

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…

Read News Item